Navigation Links
Maxygen Reports Fourth Quarter and Year End 2007 Financial Results
Date:2/12/2008

REDWOOD CITY, Calif., Feb. 12 /PRNewswire-FirstCall/ . Maxygen, Inc. (Nasdaq: MAXY), a biotechnology company focused on the development of improved protein drugs, today reported financial results for the fourth quarter and year ended December 31, 2007. At December 31, 2007, cash, cash equivalents and marketable securities totaled $145.8 million compared to $182.9 million at December 31, 2006.

"After a productive year for MAXY-G34 in the clinic, we enter 2008 in a solid cash position," said Russell Howard, Ph.D., chief executive officer of Maxygen. "With consolidation of our operations almost complete and our ongoing cash utilization streamlined, we are well positioned to focus our resources on continued advancement of our two lead programs, MAXY-G34 for neutropenia and MAXY-VII for hemophilia."

Fourth Quarter Results

For the fourth quarter of 2007, Maxygen reported a net loss of $11.3 million, or $0.31 per share, compared to net income of $8.3 million, or $0.23 per share, in the fourth quarter of 2006. Fourth quarter 2006 results were substantially impacted by a $17.7 million gain on the sale of Maxygen's equity interest in Avidia, which was acquired by Amgen in October 2006. Fourth quarter 2007 results reflect the recognition of $7.7 million of related party revenue from Maxygen's license agreement with Codexis related to biofuels. The Codexis revenue was partially offset by $5.2 million of restructuring charges associated with the closure of Maxygen's Denmark facility as announced in November 2007.

Revenue for the fourth quarter 2007 was $11.0 million, an increase of $4.5 million compared to the fourth quarter 2006. The increase was primarily due to the aforementioned $7.7 million related party revenue, and i
'/>"/>

SOURCE Maxygen, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Maxygen to Present at the Roth 20th Annual OC Growth Stock Conference
2. Maxygen to Present at the Stanford Group Company 13th Annual Healthcare Conference
3. Maxygen to Present at the JPMorgan 26th Annual Healthcare Conference
4. Maxygen Licenses Dengue Vaccine Technology to sanofi pasteur
5. Maxygen Reports Third Quarter 2007 Financial Results
6. Maxygen Announces Upcoming Webcasts at Investor Conferences
7. Maxygen Third Quarter 2007 Financial Results Conference Call Notice
8. Maxygen Announces Hold on MAXY-alpha Development Program
9. Cynosure Reports Record Revenues and Net Income for the Fourth Quarter of 2007
10. AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers
11. Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)... The Food & Drug Administration (FDA) issued in Ju... report acknowledged that nanoscale materials pote...ted by the agency and that those materials present...s relevant to product safety and effectiveness may...Anticipating the potential for rapid commercializa...
(Date:9/5/2008)...N BEACH, Calif., Sept. 5 /- Men in th...sociated with an enlarged,prostate now have the op...he problem. Orange Coast Urology of Huntington Bea...w Enhancement) procedure using the EVOLVE(R),Laser... a breakthrough,laser treatment for benign prostat...
(Date:9/5/2008)...RK, Ill., Sept. 5 /- Abbott...ericas" Investment Conference on Friday,Sept. 12,...Investor,Relations, will make a formal presentatio...ndon time)., A live audio webcast of the presenta...Relations Web site at http://www.abbottinvestor.c...
(Date:9/5/2008)...E, Ala., Sept. 5 /- Expression Geneti... novel TheraPlas(R) cancer drug,has been selected ...cts in,development available for strategic partner...ittee assembled by Windhover Information, a leadin...rvices to senior executives,in the pharmaceutical,...
Breaking Biology Technology:Nanotechnology and the FDA: size matters 2Orange Coast Urology Offers Advanced In-Office Patient EVOLVE(R) Laser Prostate Treatment 2Expression Genetics' EGEN-001 Named One of 10 Most Promising Oncology Products by Windhover 2Expression Genetics' EGEN-001 Named One of 10 Most Promising Oncology Products by Windhover 3
...Madison, Wis. — As a former attorney and cu...search Foundation (WARF), Carl Gulbrandsen certain...sks facing the U.S. Patent and Trademark Office an...ntly began serving a three-year term, have even hi...,s a very daunting thing," said Gulbrandsen, who n...
... Small Times magazine has just put out in its Ma... the U.S. Its focus is primarily on the environmen...and microtechnology companies, which will include ...tics. , ,Before I provide you with their results, ... compute their ranking. They looked at these facto...
...he University of Wisconsin,s Condor software proje... computing system at European research heavyweight...as a computing network with more than 100 sites in...uilding a grid with more than 10,000 processors, w...cessible for large-scale projects even as each loc...
... Given what passes for appropriate business attire... made a big deal out of "casual Fridays." , ,(In t... my own professional attire trajectory has gone th...at Digital Equipment Corporation, I was once asked...ur building.) , ,If you need any more evidence tha...
Other Biology Technology:Gulbrandsen tackles 'daunting' challenges in Patent Office 2Midwest states in top 10 small-tech hotspots 2Dressing information technology in business clothes 2Dressing information technology in business clothes 3
(Date:9/4/2008)..., 5 September 2008 Even scientists define ,a gene...e that the media also have various ways of framing...ppearing in the October 2008 issue of EMBO report... analysis of 300 articles in British and Norwegian...ail from the UK; and Aftenposten, Dagbladet, and V...
(Date:9/4/2008)..., Sept. 4, 2008 As the anniversary of the Septemb...ciety (ACS) has issued a new podcast describing an...ety and national security. The podcast is the six...hemistry Solutions )series. , With new episodes ...aunting problems facing society in the 21st Centur...
(Date:9/4/2008)...mputer model help stabilize the tuna population? C...thout jeopardizing food production? , Those and ...ists, applied mathematicians, economists, biologis...rnell University,s new Institute for Computational... grant from the National Science Foundation (NSF)....
(Date:9/4/2008)... Mass., Sept. 4, 2008 Declaring the success of an...opy, Los Angeles-based philanthropists Eli and Edy... their total gift to the Broad Institute of Harvar...s gifts totaling $200 million, the Broads today ga...titute, which had been launched as a 10-year "vent...
Breaking Biology News(10 mins):What is a gene? 2New 'chemical radar' among national security innovations in ACS podcast 2New 'chemical radar' among national security innovations in ACS podcast 3Cornell gets $10 million NSF grant to establish new sustainability institute 2Eli and Edythe L. Broad make unprecedented gift to endow Broad Institute of Harvard & MIT 2Eli and Edythe L. Broad make unprecedented gift to endow Broad Institute of Harvard & MIT 3Eli and Edythe L. Broad make unprecedented gift to endow Broad Institute of Harvard & MIT 4Eli and Edythe L. Broad make unprecedented gift to endow Broad Institute of Harvard & MIT 5Midwest Meets West Coast The Chicago School of Professional Psychology to Open New Campus in Downtown Los Angeles 13090 1Midwest Meets West Coast The Chicago School of Professional Psychology to Open New Campus in Downtown Los Angeles 13090 2Midwest Meets West Coast The Chicago School of Professional Psychology to Open New Campus in Downtown Los Angeles 13090 3Midwest Meets West Coast The Chicago School of Professional Psychology to Open New Campus in Downtown Los Angeles 13090 4California Dental Hygienists Offer Tips for Safe Sippy Cup Use 13089 1California Dental Hygienists Offer Tips for Safe Sippy Cup Use 13089 2Belden Appoints Mary S McLeod of Pfizer Inc to Board of Directors 13087 1Belden Appoints Mary S McLeod of Pfizer Inc to Board of Directors 13087 2URAC Invites Health Management Industry Public for Comments on Changes to Its Core Accreditation Standards 13085 1URAC Invites Health Management Industry Public for Comments on Changes to Its Core Accreditation Standards 13085 2URAC Invites Health Management Industry Public for Comments on Changes to Its Core Accreditation Standards 13085 3
...or the first time, researchers have enticed transp... in the spinal cord to connect with muscles and pa... study suggests that similar techniques may be use...ury, transverse myelitis, amyotrophic lateral scle...y was funded in part by the NIH,s National Institu...
... computer model newly developed by researchers com...sting to help scientists predict animal dispersion...s across the Caribbean Sea. The work is reported b...nford University, and Donald B. Olson of the Unive...ue of Current Biology, published by Cell Press. ...
...he ability to spot venomous snakes may have played...d humans, according to a new hypothesis by Lynne I...work is published in the July issue of the Journal... enlarged brains, and grasping hands and feet, and...Scientists have thought that these characteristics...
...n a finding that broadens our understanding of tim...ve discovered that an insect pollinator, the bumbl.... Although many insects show daily and annual rhyt... estimate the duration of shorter time intervals h...vertebrates. , The findings are reported by Mich...
Other Biology News:Neurons grown from embryonic stem cells restore function in paralyzed rats 2Neurons grown from embryonic stem cells restore function in paralyzed rats 3Neurons grown from embryonic stem cells restore function in paralyzed rats 4Seeing the serpent 2
jub, ajuba homolog (Xenopus laevis)
Recommend to use at up to 5000X dilutions for cell culture (e.g. Add 1 ul to 1 ml of culture medium.)
Prepared in distilled water.
...rs, 37 kBq, 1 uCi. Carbon-14 radiolabelled marker ...the sample on Western blots.The Rainbow-labeled ve...ion in the gel and on the blot.The specific activi...s 0.37-3.7 MBq/mg (10-100 uCi/mg) or 185 kBq/ml (5...
Biology Products: